Operating Lease, Right-of-Use Asset of Oncternal Therapeutics, Inc. from 30 Jun 2019 to 30 Sep 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Oncternal Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 30 Jun 2019 to 30 Sep 2024.
  • Oncternal Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2024 was $154,000, a 47% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Oncternal Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2024 $154,000 -$137,000 -47% 30 Sep 2024 10-Q 06 Nov 2024 2024 Q3
Q2 2024 $190,000 -$176,000 -48% 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 $225,000 +$175,000 +350% 31 Mar 2024 10-Q 09 May 2024 2024 Q1
Q4 2023 $258,000 +$171,000 +197% 31 Dec 2023 10-Q 06 Nov 2024 2024 Q3
Q3 2023 $291,000 +$169,000 +139% 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 $366,000 +$209,000 +133% 30 Jun 2023 10-Q 10 Aug 2023 2023 Q2
Q1 2023 $50,000 +$19,000 +61% 31 Mar 2023 10-Q 04 May 2023 2023 Q1
Q4 2022 $87,000 +$12,000 +16% 31 Dec 2022 10-K 07 Mar 2024 2023 FY
Q3 2022 $122,000 +$3,000 +2.5% 30 Sep 2022 10-Q 03 Nov 2022 2022 Q3
Q2 2022 $157,000 -$5,000 -3.1% 30 Jun 2022 10-Q 09 Aug 2022 2022 Q2
Q1 2022 $31,000 -$173,000 -85% 31 Mar 2022 10-Q 05 May 2022 2022 Q1
Q4 2021 $75,000 +$35,000 +88% 31 Dec 2021 10-K 09 Mar 2023 2022 FY
Q3 2021 $119,000 +$40,000 +51% 30 Sep 2021 10-Q 04 Nov 2021 2021 Q3
Q2 2021 $162,000 +$45,000 +38% 30 Jun 2021 10-Q 05 Aug 2021 2021 Q2
Q1 2021 $204,000 +$50,000 +32% 31 Mar 2021 10-Q 06 May 2021 2021 Q1
Q4 2020 $40,000 -$150,000 -79% 31 Dec 2020 10-K 10 Mar 2022 2021 FY
Q3 2020 $79,000 -$147,000 -65% 30 Sep 2020 10-Q 04 Nov 2020 2020 Q3
Q2 2020 $117,000 -$148,000 -56% 30 Jun 2020 10-Q 06 Aug 2020 2020 Q2
Q1 2020 $154,000 31 Mar 2020 10-Q 07 May 2020 2020 Q1
Q4 2019 $190,000 31 Dec 2019 10-K/A 12 Mar 2021 2020 FY
Q3 2019 $226,000 30 Sep 2019 10-Q 08 Nov 2019 2019 Q3
Q2 2019 $265,000 30 Jun 2019 10-Q 09 Aug 2019 2019 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.